AstraZeneca moves to placate shareholders over chief executive’s £14m pay by promising to freeze his bonus package for three years By Alex Lawson, Financial Mail On Sunday Published: 16:51 EST, 26 February 2022 | Updated: 16:51 EST, 26 February 2022 AstraZeneca has
Breast cancer breakthrough boost at AstraZeneca: Enhertu drug shows positive results in late-stage trial By Calum Muirhead For The Daily Mail Published: 17:26 EST, 21 February 2022 | Updated: 17:26 EST, 21 February 2022 Positive news about one of its breast cancer
June 2021 and on Centre Court at Wimbledon, the opening match is about to begin after a two-year Covid-enforced hiatus for the tennis tournament. But first, some VIP guests are introduced to the spectators. ‘Throughout this coming fortnight, the club’s chairman has
AstraZeneca shares jump as pharma giant hails ‘huge step forward’ with successful trial of breast cancer drug Around 540 patients from Asia, Europe, and the US were involved in the trial Enhertu was shown to have slowed the progression of metastatic breast
AstraZeneca shares rise as trial shows drug could help prolong life of terminally ill prostate cancer patients Trial shows treatment delays disease progression by more than eight months Prostate cancer is the most common cancer in men in the UK Astrazeneca shares
Shares in AstraZeneca surged following good news about the effectiveness of one of its cancer drugs. The pharma giant bounced 5.8 per cent, or 484p, to 8864p after results from a phase III clinical trial showed its lynparza drug, when used alongside
Britons under 40 will be offered an alternative to the Oxford/AstraZeneca Covid jab after it was linked to potentially fatal blood clots, it was claimed last night. Advisers are understood to have written to Health Secretary Matt Hancock suggesting the move after
Only SIX out of 6million Britons given AstraZeneca’s Covid jab have suffered blood clots after their second dose, official data shows UK regulator revealed six cases of clots in fully vaccinated Brits in weekly update Until now had only been found in
Man, 66, is in intensive care with blood clots after receiving the AstraZeneca Covid vaccine By Alana Mazzoni For Daily Mail Australia Published: 22:45 EDT, 5 May 2021 | Updated: 22:45 EDT, 5 May 2021 A 66-year-old Queensland man is in intensive
Risk of blood clots after AstraZeneca Covid jab is ‘small’ and people are three times more likely to die if they aren’t vaccinated Researchers in Denmark and Norway looked at nationwide rates of blood clots Found slightly increased rates of vein clots